Market Movers (8-K)
See all →NASDAQ
CROX
Crocs, INCCrocs, Inc. announced record second quarter 2026 results, with the Crocs Brand exceeding $1 billion in quarterly revenue for the first time, leading to an increased full-year financial outlook.
Better than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. announced the approval of its 2026 Equity Incentive Plan by stockholders at its annual meeting, replacing the prior 2020 plan.
NASDAQ
CROX
Crocs, INCCrocs, Inc. announced first quarter 2026 financial results, exceeding expectations and leading to an upward revision of its full-year financial outlook.
Better than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. reported better-than-expected full-year 2025 results with revenue exceeding $4 billion, despite significant impairment charges related to the HEYDUDE brand.
Better than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. reported a 6.2% revenue decline in Q3 2025, with strong international Crocs brand performance offset by significant HEYDUDE brand weakness, while initiating further cost savings.
Better than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. announced the appointment of Patraic Reagan as its new Executive Vice President and Chief Financial Officer, effective September 22, 2025, following Susan Healy's resignation, and reaffirmed its third-quarter 2025 financial outlook.
Quarterly Earnings (10-Q)
See all →NASDAQ
CROX
Crocs, INCCrocs, Inc. announced its second quarter 2026 financial results, reporting a 2.6% increase in revenue to $1.18 billion and a return to net income.
NASDAQ
CROX
Crocs, INCCrocs, Inc. reported a 1.7% decrease in Q1 2026 revenue to $921.5 million, with gross margin declining due to duties and product mix, while net income fell 14.1%.
Worse than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. reported a 6.2% revenue decrease in Q3 2025 and a significant net loss for the nine months ended September 30, 2025, primarily due to substantial impairment charges related to its HEYDUDE brand.
Worse than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. reported a significant net loss for Q2 2025, primarily driven by a substantial impairment charge related to its HEYDUDE brand.
Worse than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. experienced a slight revenue decrease in Q1 2025, offset by gross margin improvements, while navigating potential tariff impacts and ongoing legal proceedings.
Worse than expected
NASDAQ
CROX
Crocs, INCCrocs Inc. saw a slight revenue increase in Q3 2024, driven by the Crocs brand, but faced challenges with the HEYDUDE brand and increased operating expenses.
Worse than expected
Annual Reports (10-K)
NASDAQ
CROX
Crocs, INCCrocs, Inc. reported a net loss of $81.2 million for fiscal year 2025, primarily due to significant impairment charges related to its HEYDUDE Brand, despite revenue growth in the Crocs Brand.
Worse than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. announces a 3.5% revenue increase for 2024, driven by the Crocs Brand, while addressing economic challenges and strategic growth initiatives.
NASDAQ
CROX
Crocs, INCCrocs, Inc. amends its term loan for better rates and files its annual report, highlighting growth, strategic initiatives, and a commitment to environmental, social, and governance (ESG) practices.
Better than expected
Insider Trading (Form 4)
See all →NASDAQ
CROX
Crocs, INCForm 4: Crocs CEO Sells Shares
Andrew Rees, Chief Executive Officer and a Director of Crocs, Inc., sold 30,000 shares of common stock on August 7, 2026.
NASDAQ
CROX
Crocs, INCAndrew Rees, Chief Executive Officer and a Director of Crocs, Inc., reported multiple transactions in common stock on August 4, 2026.
NASDAQ
CROX
Crocs, INCCrocs, Inc. director Ronald Frasch acquired 1,252 shares of common stock as part of the company's annual director compensation plan.
NASDAQ
CROX
Crocs, INCCrocs, Inc. director Ian Bickley acquired 1,252 shares of common stock as part of the company's annual director compensation plan.
NASDAQ
CROX
Crocs, INCCrocs, Inc. director Charisse Ford Hughes was granted 1,252 restricted stock units as part of the company's annual non-employee director compensation plan.
NASDAQ
CROX
Crocs, INCCrocs, Inc. director Beth Kaplan acquired 1,252 shares of common stock as part of the company's annual director compensation plan.
Proxy Statements (Def-14A)
NASDAQ
CROX
Crocs, INCCrocs, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, ratify auditors, and approve a new equity incentive plan.
Worse than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to its upcoming shareholder meeting.
NASDAQ
CROX
Crocs, INCDEF: Crocs, Inc. Announces 2025 Annual Meeting of Stockholders and Details 2024 Financial Performance
Crocs, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 10, 2025, and the proxy statement details the company's 2024 financial performance and proposals for stockholder voting.
Better than expected
NASDAQ
CROX
Crocs, INCCrocs, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
CROX
Crocs, INCDEF 14A: Crocs, Inc. Announces 2024 Annual Meeting of Stockholders and Executive Compensation Details
Crocs, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, to elect directors, ratify the independent auditor, and vote on executive compensation.
Better than expected
Schedule 13G - Passive Investments
See all →NASDAQ
CROX
Crocs, INCSCHEDULE: FMR LLC Reports 7.1% Stake in Crocs Inc.
FMR LLC and Abigail P. Johnson have updated their beneficial ownership filing for Crocs Inc., reporting a combined 7.1% stake as of June 30, 2026.
NASDAQ
CROX
Crocs, INCWIT Partners Advisory Pte. Ltd. has disclosed beneficial ownership of 2,852,280 shares, representing 5.3% of Crocs, Inc.'s common stock, as of February 28, 2025.
NASDAQ
CROX
Crocs, INCVanguard Capital Management has reported beneficial ownership of 5.1% of Crocs Inc. common stock as of March 31, 2026.
NASDAQ
CROX
Crocs, INCThe Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Crocs Inc. following an internal realignment that disaggregated reporting.
NASDAQ
CROX
Crocs, INCSCHEDULE: FMR LLC Boosts Crocs Stake to 8.2%
FMR LLC and its affiliates, including Abigail P. Johnson, reported beneficial ownership of 8.2% of Crocs Inc.'s common stock as of December 31, 2025.
NASDAQ
CROX
Crocs, INCWIT Partners Advisory Pte. Ltd. has reported a 5.32% beneficial ownership stake in Crocs, Inc. common stock.